Patents for C07C - Acyclic or carbocyclic compounds (5,682) |
---|
03/24/2005 | US20050065386 Method for the preparation of n-propyl bromide |
03/23/2005 | EP1515948A1 Process for the formation and isolation of carotenoid crystals |
03/23/2005 | EP1515939A2 Method for preparing an unsaturated carboxylic acid |
03/23/2005 | EP1515926A2 Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia |
03/23/2005 | CN1599714A Process for the continuous quaternisation of tertiary amines with an alkyl halide |
03/23/2005 | CN1599712A Process for the preparation of methionine |
03/23/2005 | CN1599710A Production of ammonium salts of aromatic carboxylic acids |
03/23/2005 | CN1597659A Process for preparing n-methyldialkylamines from secondary dialkylamines and formaldehyde |
03/17/2005 | WO2004112690A3 2-aminobenzoyl derivatives |
03/17/2005 | WO2002096865A8 Process for the preparation 3-aryl-2-hydroxypropionic acid derivative |
03/16/2005 | EP1514559A1 Arylpiperazines having activity at the serotonin 1a receptor |
03/16/2005 | EP1513800A1 N-benzoylureidocinnamate derivatives, method for production and use thereof |
03/10/2005 | WO2005021467A2 An integrated fischer-tropsch process for production of linear and branched alcohols and olefins |
03/10/2005 | WO2005003065A3 Sulfonamide substituted imidazoquinolines |
03/10/2005 | WO2004067481A3 Improved jasmine aromachemicals |
03/10/2005 | US20050053559 Carotenoid composition and method for protecting skin |
03/09/2005 | CN1590386A Sidechain-bearing taxanes and method for the preparation thereof |
03/09/2005 | CN1590363A Crystallized pravastatin sodium salt and its preparing process |
03/09/2005 | CN1192016C Process for preparation of 4-(des-dimethylamino)-tetracyclines |
03/09/2005 | CN1192011C Calcium receptor-active arylalkyl amines |
03/03/2005 | US20050049304 comprises the steps of preparing a mixture of venlafaxine with acetone then exposing the mixture to gaseous hydrochloric acid |
03/02/2005 | CN1589257A N-methyl-homocysteines and their use as well as process for their production |
03/02/2005 | CN1589256A Polycrystalline forms of sertraline hydrochloride and compeosition containing them, and method for preparing sertraline hydrochloride polycrystalline forms and amorphous matter |
03/02/2005 | CN1589251A 加氢甲酰化方法 Hydroformylation process |
03/02/2005 | CN1589250A Process for the hydrogenation of acetone |
03/02/2005 | CN1589136A Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes |
03/01/2005 | CA2288334C Method of manufacturing sertindole |
02/24/2005 | WO2005016229A2 Use of lipophilic diesters of chelating agent for the treatment of amyloidosis and atherosclerosis |
02/23/2005 | CN1585629A Carotenoid composition and method for protecting skin |
02/22/2005 | US6858652 Sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them |
02/22/2005 | US6858571 Pentafluoropropene-based compositions |
02/22/2005 | CA2129039C Tri-substituted phenyl derivatives as phosphodiesterase inhibitors |
02/17/2005 | WO2005014510A2 AUTOMATED SEPARATION, PURIFICATION AND LABELING SYSTEMS FOR 60CU, 61Cu and 64Cu RADIONUCLIDES AND RECOVERY THEREOF |
02/17/2005 | WO2004078680A3 Method for reducing the allergenic protein content of natural rubber latex articles |
02/17/2005 | US20050038124 Highly pure modafinil |
02/17/2005 | US20050038119 for treatment of neutrofil-dependent pathologies such as psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), bollous pemphigo, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis; prevention and treatment of damages caused by ischemia and reperfusion |
02/17/2005 | US20050034652 Crystalline forms of modafinil |
02/16/2005 | EP1506171A1 Preparations of a sulfinyl acetamide |
02/10/2005 | WO2004103935A3 Cyclic carbothioic acid derivatives |
02/10/2005 | US20050033076 Coordination polymerization catalysts |
02/09/2005 | CN1188405C New Morpholinobenzamide salts |
02/03/2005 | WO2005009926A2 A synthetic lubricant basestock and an integrated fischer-tropsch process for its production |
02/02/2005 | CN1575275A Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives |
02/02/2005 | CN1187318C Solid composition suitable for oral administration comprising non hydroscopic salts of L-carnitine or alkanoyl-L-carnitine with 2-aminoethanesulfonic acid |
02/01/2005 | US6849120 Oxidizing 2-((diphenylmethyl)thio)acetamide with hydrogen peroxide in mixture of mineral acid with alcohol or phase transfer catalyst, precipitating solid, and separating |
01/27/2005 | WO2005007600A2 Novel methods using aminobenzoic acid compounds |
01/27/2005 | US20050020677 Compounds having prolyl oligopeptidase inhibitory activity, methods for their preparation and their use |
01/27/2005 | US20050020481 Ion channel modulating compounds and uses thereof |
01/27/2005 | US20050020474 Process for the continuous quaternisation of tertiary amines with an alkyl halide |
01/27/2005 | US20050020450 Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives |
01/27/2005 | US20050016899 Synthetic lubricant basestock and an integrated fischer-tropsch process for its production |
01/26/2005 | EP1499586A1 Novel form of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine |
01/26/2005 | EP1499582A1 Method for chlorinating tertiary alcohols |
01/26/2005 | CN1571658A Pharmaceutical formulation comprising (R)-bicalutamide |
01/25/2005 | US6846962 Selective production of o-alkylphenols |
01/20/2005 | WO2005005346A2 Polymerizable adamantane derivative, process for producing the same, and polymer |
01/20/2005 | WO2004074218A3 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
01/20/2005 | WO2004037913A3 Compositions containing flourine substituted olefins |
01/20/2005 | US20050014955 Process for the preapartion 3-aryl-2-hydroxypropionic acid derivative |
01/19/2005 | CN1566096A Prostaglandin agonists and their use to treat bonedisorders |
01/13/2005 | WO2005003066A2 Distillation of a fischer-tropsch derived hydrocarbon stream |
01/13/2005 | WO2005003065A2 Sulfonamide substituted imidazoquinolines |
01/13/2005 | WO2005003064A2 Sulfonamide substituted imidazoquinolines |
01/13/2005 | WO2005003062A2 Process for production of fluorinated sulfonyl fluorides |
01/13/2005 | US20050009920 Taxol enhancer compounds |
01/13/2005 | CA2529322A1 Sulfonamide substituted imidazoquinolines |
01/12/2005 | EP1112246B1 Microbial process for the preparation of acetic acid as well as solvents for its extraction from the fermentation broth |
01/06/2005 | WO2005000794A1 Propionamide derivatives useful as androgen receptor modulators |
01/06/2005 | US20050004412 Distillation of a Fischer-Tropsch derived hydrocarbon stream |
01/06/2005 | US20050004393 Passing gaseous ammonia through solution of aromatic carboxylic acid in aprotic solvent; narrow molecular weight distribution |
01/06/2005 | US20050003448 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
01/05/2005 | CN1183068C Process for production of olefins |
12/30/2004 | US20040265846 Screening point mutations to diagnose cardiovascular diseases, psychiatric diseases, or cancer; binding proteins; monoclonal antibodies; kits |
12/29/2004 | WO2004112690A2 2-aminobenzoyl derivatives |
12/29/2004 | WO2004063129A3 Methods for nucleophilic fluoromethylation |
12/29/2004 | WO2004046068A3 Non-steroidal farnesoid x receptor modulators and methods for the use thereof |
12/28/2004 | US6835751 Bicyclic amino acids as pharmaceutical agents |
12/22/2004 | EP1487771A1 Fluorination of dicarbonyl compounds |
12/22/2004 | EP1080066A4 Bioreductive cytotoxic agents |
12/16/2004 | WO2004108636A2 Isotopically labeled chemically stable reagents and process for the synthesis thereof |
12/16/2004 | WO2004108635A2 Mixed zeaxanthin ester concentrate and uses thereof |
12/16/2004 | WO2004108070A2 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
12/16/2004 | WO2004060832B1 Fluorescent creatinine assay |
12/16/2004 | CA2526007A1 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
12/15/2004 | EP1485343A1 Amorphous hmg-coa reductase inhibitors of desired particle size |
12/15/2004 | CN1179936C Preparation method for cyclopropane esters |
12/09/2004 | WO2004067486A3 Process for the preparation of and composition of a feedstock usable for the preparation of lower olefins |
12/09/2004 | US20040248864 Use of anthroquinones in the treatment of kidney disease |
12/08/2004 | CN1553895A Taxol enhancer compounds |
12/08/2004 | CN1553894A Taxol enhancer compounds |
12/08/2004 | CN1178899C Preparation of iodixanol |
12/02/2004 | WO2004103935A2 Cyclic carbothioic acid derivatives |
12/01/2004 | EP1480948A1 Semicarbazide derivatives and their use as antithrombotics |
12/01/2004 | EP1480932A2 Method for production of beta-cryptoxanthin and alpha-cryptoxanthin from commercially available lutein |
12/01/2004 | CN1177793C Microbial process for preparing pravastatin |
11/25/2004 | WO2004101473A2 Under-neutralized alkylxylene sulfonic acid composition for enhanced oil recovery processes |
11/25/2004 | US20040236149 Microbial process for the preparation of acetic acid, as well as solvent for its extraction from the fermentation broth |
11/25/2004 | US20040235909 substituted bis/thiohydrazide amide compound; synergistic effect with taxol or taxotere, anticancer agents, side effect reduction |
11/25/2004 | US20040235841 For therapy and prophylaxis of diseases and disorders associated with cyclin-dependent kinases (CDKs) activity |
11/24/2004 | EP1478615A1 Brominated esters, methods for their preparation and use thereof as flame retardants |